| PHARMACIA & UPJOHN COMPANY LLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20110098266 | METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL - A method of administering an antibiotic to an animal in need thereof, including the step of injecting the antibiotic subcutaneously at the junction of a pinna with the cranium of the animal, is disclosed. | 04-28-2011 |
| 20100322975 | Anti-bacterial Vaccine Compositions - Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines. | 12-23-2010 |
| 20100273238 | Cellular Permissivity Factor for Viruses and Uses Thereof - The present invention provides methods and compositions related to the generation of host cells permissive for virus growth, particularly Porcine Reproductive and Respiratory Syndrome (PRRS) virus. | 10-28-2010 |
| 20100173854 | Microfluidized Oil-in-water Emulsions and Vaccine Compositions - This invention provides submicron oil-in-water emulsions useful as a vaccine adjuvant for enhancing the immunogenicity of antigens. The present invention also provides vaccine compositions containing an antigen combined with such emulsions intrinsically or extrinsically. Methods of preparing the emulsions and vaccines are also provided by the present invention. | 07-08-2010 |
| 20100093820 | CRYSTALLINE PYRAZOLES - The present invention relates to crystal forms of 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide and methods for preparation, interconversion, and isolation of such crystals. | 04-15-2010 |
| 20090117103 | M-CSF Antibody compositions Having Reduced Levels of Endotoxin - The present invention provides for compositions of anti-M-CSF antibodies that are substantially free of endotoxin. Also provided are methods of treating M-CSF-mediated disorders with pharmaceutical formulations of anti-M-CSF antibodies having reduced endotoxin levels, including inflammatory diseases and neoplasia disorders. | 05-07-2009 |
